Is intraoperative touch imprint cytology of sentinel lymph nodes in patients with breast cancer cost effective?

Cancer

Volumn 107, Issue 10, 2006, Pages 2328-2336

  Jeruss, Jacqueline S ^a   Hunt, Kelly K ^a   Xing, Yan ^a   Krishnamurthy, Savitri ^a   Meric Bernstam, Funda ^a   Cantor, Scott B ^a   Ross, Merrick I ^a   Cormier, Janice N ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Breast cancer; Cost analysis; Sentinel nods biopsy; Touch imprint cytology

Indexed keywords

ARTICLE; BIOMEDICAL TECHNOLOGY ASSESSMENT; BREAST CANCER; CANCER CYTODIAGNOSIS; CONTROLLED STUDY; COST BENEFIT ANALYSIS; COST UTILITY ANALYSIS; DECISION SUPPORT SYSTEM; FEMALE; HEALTH CARE COST; HUMAN; INTERMETHOD COMPARISON; INTRAOPERATIVE PERIOD; MAJOR CLINICAL STUDY; MASTECTOMY; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR; SENSITIVITY AND SPECIFICITY; SENTINEL LYMPH NODE BIOPSY; TOUCH IMPRINT CYTOLOGY;

ALGORITHMS; BREAST NEOPLASMS; CARCINOMA, LOBULAR; COMPUTER SIMULATION; COST-BENEFIT ANALYSIS; CYTODIAGNOSIS; DECISION SUPPORT TECHNIQUES; HUMANS; INTRAOPERATIVE PERIOD; LYMPH NODES; LYMPHATIC METASTASIS; SENSITIVITY AND SPECIFICITY; SENTINEL LYMPH NODE BIOPSY; TREATMENT OUTCOME;

EID: 33750998517     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.22275     Document Type: Article

References (32)

1. Purushotham AD, Upponi S, Klevesath MB, et al. Morbidity after sentinel lymph node biopsy in primary breast cancer: results from a randomized controlled trial. J Clin Oncol. 2005;23:4312-4321.
2. Seigler HF. Axillary lymph node dissection versus the sentinel lymph node technique in breast cancer. Ann Surg. 2004;240:7-8.
3. Alex JC, Krag DN. Gamma-probe guided localization of lymph nodes. Surg Oncol. 1993;2:137-143.
4. Giuliano AE, Kirgan DM, Guenther JM, Morton DL. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg. 1994;220:391-398.
5. Krag D, Weaver D, Ashikaga T, et al. The sentinel node in breast cancer-a multicenter validation study. N Engl J Med. 1998;339:941-946.
6. Winchester DJ, Sener SF, Winchester DP et al. Sentinel lymphadenectomy for breast cancer: experience with 180 consecutive patients: efficacy of filtered technetium 99m sulphur colloid with overnight migration time. J Am Coll Surg. 1999;188:597-603.
7. Fleissig A, Fallowfield LJ, Langridge CI, et al. Post-operative arm morbidity and quality of life. Results of the ALMANAC randomised trial comparing sentinel node biopsy with standard axillary treatment in the management of patients with early breast cancer. Breast Cancer Res Treat. 2006;95:279-293.
8. James TA, Edge SB. Sentinel lymph node in breast cancer. Curr Opin Obstet Gynecol. 2006;18:53-58.
9. Van Diest PJ, Torrenga H, Borgstein PJ, et al. Reliability of intraoperative frozen section and imprint cytological investigation of sentinel lymph nodes in breast cancer. Histopathology. 1999;35:14-18.
10. Lee A, Krishnamurthy S, Sahin A, Symmans WF, Hunt K, Sneige N. Intraoperative touch imprint of sentinel lymph nodes in breast carcinoma patients. Cancer. 2002;96:225-231.
11. Karamlou T, Johnson NM, Chan B, Franzini D, Mahin D. Accuracy of intraoperative touch imprint cytologic analysis of sentinel lymph nodes in breast cancer. Am J Surg. 2003;185:425-428.
12. Tew K, Irwig L, Matthews A, Crowe P, Macaskill P. Meta-analysis of sentinel node imprint cytology in breast cancer. Br J Surg. 2005;92:1068-1080.
13. Kane JM, 3rd, Edge SB, Winston JS, Watroba N, Hurd TC. Intraoperative pathologic evaluation of a breast cancer sentinel lymph node biopsy as a determinant for synchronous axillary lymph node dissection. Ann Surg Oncol. 2001;8:361-367.
14. Menes TS, Tartter PI, Mizrachi H, Smith SR, Estabrook A. Touch preparation or frozen section for intraoperative detection of sentinel lymph node metastases from breast cancer. Ann Surg Oncol 2003;10:1166-1170.
15. Brogi E, Torres-Matundan E, Tan LK, Cody HS 3rd. The results of frozen section, touch preparation, and cytological smear are comparable for intraoperative examination of sentinel lymph nodes: a study in 133 breast cancer patients. Ann Surg Oncol. 2005;12:173-180.
16. Gupta R, Sinnett D, Carpenter R, Preece PE, Royle GT. Antibiotic prophylaxis for post-operative wound infection in clean elective breast surgery. Eur J Surg Oncol. 2000;26:363-366.
17. Rabin R, de Charro F. EQ-5D: a measure of health status from the EuroQol Group. Ann Med. 2001;33:337-343.
18. Chung MH, Ye W, Giuliano AE. Role for sentinel lymph node dissection in the management of large (> or = 5 cm) invasive breast cancer. Ann Surg Oncol. 2001;8:688-692.
19. Weaver DL, Krag DN, Ashikaga T, Harlow SP, O'Connell M. Pathologic analysis of sentinel and nonsentinel lymph nodes in breast carcinoma: a multicenter study. Cancer. 2000;88:1099-1107.
20. Leidenius M, Krogerus L, Tukiainen E, von Smitten K. Accuracy of axillary staging using sentinel node biopsy or diagnostic axillary lymph node dissection-a case-control study. APMIS. 2004;112:264-270.
21. Dabbs DJ, Fung M, Landsittel D, McManus K, Johnson R. Sentinel lymph node micrometastasis as a predictor of axillary tumor burden. Breast J. 2004;10:101-105.
22. Viale G, Zurrida S, Maiorano E, et al. Predicting the status of axillary sentinel lymph nodes in 4351 patients with invasive breast carcinoma treated in a single institution. Cancer. 2005;103:492-500.
23. Tan YY, Wu CT, Fan YG, et al. Primary tumor characteristics predict sentinel lymph node macrometastasis in breast cancer. Breast J. 2005;11:338-343.
24. Jeruss JS, Winchester DJ, Sener SF, et al. Axillary recurrence after sentinel node biopsy. Ann Surg Oncol. 2005;12:34-40.
25. Creager AJ, Geisinger KR, Perrier ND, et al. Intraoperative imprint cytologic evaluation of sentinel lymph nodes for lobular carcinoma of the breast. Ann Surg. 2004;239:61-66.
26. Chicken DW, Kocjan G, Falzon M, et al. Intraoperative touch imprint cytology for the diagnosis of sentinel lymph node metastases in breast cancer. Br J Surg. 2006;93:572-576.
27. Jain P, Kumar R, Anand M, et al. Touch imprint cytology of axillary lymph nodes after neoadjuvant chemotherapy in patients with breast carcinoma. Cancer. 2003;99:346-351.
28. Foster RS Jr. The biologic and clinical significance of lymphatic metastases in breast cancer. Surg Oncol Clin N Am. 1996;5:79-104.
29. Ververs JM, Roumen RM, Vingerhoets AJ, et al. Risk, severity and predictors of physical and psychological morbidity after axillary lymph node dissection for breast cancer. Eur J Cancer. 2001;37:991-999.
30. Hall A, A'Hern R, Fallowfield L. Are we using appropriate self-report questionnaires for detecting anxiety and depression in women with early breast cancer? Eur J Cancer. 1999;35:79-85.
31. Arnsberger P, Fox P, Ryder P, Nussey B, Zhang X, Otero-Sabogal R. Timely follow-up among multicultural women with abnormal mammograms. Am J Health Behav. 2006;30:51-61.
32. Cohen DJ, Baim DS. Coronary stenting: costly or cost-effective? J Invasive Cardiol. 1995;7 suppl A:36A-42A.